cms.bioaccessla.com

Author: Julio Martinez-Clark

  • ILS Clinical Research vs a First-in-Human Device CRO (bioaccess®)

    If you typed ILS Clinical Research into a search box, you are probably building a CRO or site shortlist for Mexico. This article uses only what is public about ILS Clinical Research (ClinicalTrials.gov NCT03460743) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What ILS Clinical Research publishes

    ILS Clinical Research is a Mexican clinical research organization. It is listed as a collaborator, alongside EPIC Research CRO and Q Square Solutions, on a Laboratorios Liomont quadrivalent influenza vaccine study (NCT03460743). ILS Clinical Research S.A.C. also appears in the Peru INS register of research organizations.

    ILS Clinical Research vs bioaccess®

    Dimension ILS Clinical Research bioaccess®
    Core focus Drug and vaccine clinical research, Mexico First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need a Mexican partner with drug and vaccine study experience, ILS Clinical Research’s public record matches.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including ILS Clinical Research, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Mexico. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the ILS Clinical Research public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • Estudios Clínicos Internacionales (ECI) vs a First-in-Human Device CRO (bioaccess®)

    If you typed Estudios Clínicos Internacionales (ECI) into a search box, you are probably building a CRO or site shortlist for Mexico. This article uses only what is public about Estudios Clínicos Internacionales (LinkedIn company page) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What Estudios Clínicos Internacionales publishes

    Estudios Clínicos Internacionales (ECI) is a clinical research company in Puebla, Mexico. Its public company profile describes conducting clinical trials for pharmaceutical sponsors seeking to bring products to new markets.

    Estudios Clínicos Internacionales vs bioaccess®

    Dimension Estudios Clínicos Internacionales bioaccess®
    Core focus Drug clinical trials, Puebla First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need a Mexico-based team for pharmaceutical clinical trials, ECI’s published profile matches.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Estudios Clínicos Internacionales, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Mexico. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the Estudios Clínicos Internacionales public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • Accelerated Clinical Research (ACR) vs a First-in-Human Device CRO (bioaccess®)

    If you typed Accelerated Clinical Research (ACR) into a search box, you are probably building a CRO or site shortlist for Mexico. This article uses only what is public about Accelerated Clinical Research (acresearch.net) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What Accelerated Clinical Research publishes

    Accelerated Clinical Research describes itself as an international clinical trials consulting company with offices in Mexico City and Las Vegas. Its site lists clinical and regulatory strategy, human clinical trials (site screening, site management, monitoring, regulatory submissions, import/export) and health outcomes work, focused on medical devices, drug/device combination products and biologics.

    Accelerated Clinical Research vs bioaccess®

    Dimension Accelerated Clinical Research bioaccess®
    Core focus Device and combination-product consulting, Mexico First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need a Mexico-focused consulting partner for regulatory submissions and site work on a device or combination product, ACR’s published services match.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Accelerated Clinical Research, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Mexico. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the Accelerated Clinical Research public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • Althian Clinical Research vs a First-in-Human Device CRO (bioaccess®)

    If you typed Althian Clinical Research into a search box, you are probably building a CRO or site shortlist for Mexico. This article uses only what is public about Althian Clinical Research (althian.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What Althian Clinical Research publishes

    Althian describes itself as a boutique CRO based in Monterrey, Mexico, supporting pharmaceutical, biotechnology and medical device companies. Its site lists clinical trial management, regulatory affairs, pharmacovigilance, early-phase trials, data management, site monitoring and auditing, and real-world evidence. Althian appears as a study location on ClinicalTrials.gov records such as NCT02907177 and NCT05907122.

    Althian Clinical Research vs bioaccess®

    Dimension Althian Clinical Research bioaccess®
    Core focus Boutique CRO in Monterrey: trial management, RA, PV First-in-human and early feasibility studies for medical devices
    Geography See provider site Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need a boutique Mexico-based team for drug or biotech trial management, regulatory and pharmacovigilance, Althian’s published services match.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Althian Clinical Research, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the local regulatory path, see CRO in Mexico. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the Althian Clinical Research public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • Socios En Salud Peru vs a First-in-Human Device CRO (bioaccess®)

    If you typed Socios En Salud into a search box, you are probably building a CRO or site shortlist for Peru. This article uses only what is public about Socios En Salud (sociosensalud.org.pe) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What Socios En Salud publishes

    Socios En Salud is the Peruvian affiliate of Partners In Health. Its website describes health programs and research, with a long record in tuberculosis and MDR-TB. Socios En Salud Sucursal Perú appears as ROIC-257 in the INS register of research organizations (OIC), and it is listed on ClinicalTrials.gov records alongside academic partners.

    Socios En Salud vs bioaccess®

    Dimension Socios En Salud bioaccess®
    Core focus Partners In Health affiliate: TB/MDR-TB and global health research First-in-human and early feasibility studies for medical devices
    Geography Peru (Lima) Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need a research partner for tuberculosis or global-health studies in Peru, Socios En Salud’s public record matches.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Socios En Salud, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the Peru regulatory path, see CRO in Peru: the First-in-Human CRO on the INS file. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the Socios En Salud public pages linked above, Peru’s INS public registers and ClinicalTrials.gov, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • ACLIRES Peru vs a First-in-Human Device CRO (bioaccess®)

    If you typed ACLIRES into a search box, you are probably building a CRO or site shortlist for Peru. This article uses only what is public about ACLIRES (LinkedIn company page) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What ACLIRES publishes

    ACLIRES-PERU S.A.C. is the Peruvian entity linked to Aclires International, a boutique CRO whose public company profile describes drug clinical research services, including infectious disease. ACLIRES-PERU appears as ROIC-232 in the INS register of research organizations (OIC).

    ACLIRES vs bioaccess®

    Dimension ACLIRES bioaccess®
    Core focus Boutique drug CRO (Peru entity of Aclires International) First-in-human and early feasibility studies for medical devices
    Geography Peru (Lima) Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need a boutique drug CRO with a Peru registration, ACLIRES’ published profile matches.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including ACLIRES, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the Peru regulatory path, see CRO in Peru: the First-in-Human CRO on the INS file. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the ACLIRES public pages linked above, Peru’s INS public registers and ClinicalTrials.gov, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • Genexion Peru vs a First-in-Human Device CRO (bioaccess®)

    If you typed Genexion into a search box, you are probably building a CRO or site shortlist for Peru. This article uses only what is public about Genexion (INS register of research organizations (OIC)) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What Genexion publishes

    Genexion S.A.C. (Genexion Perú) is a Lima-based (Miraflores) research organization registered in the INS register of research organizations (OIC) (ROIC-200/315). We did not find a current company website. Public INS trial listings associate it with Phase III drug research.

    Genexion vs bioaccess®

    Dimension Genexion bioaccess®
    Core focus Peru drug research organization (INS-registered) First-in-human and early feasibility studies for medical devices
    Geography Peru (Lima) Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need an INS-registered local organization for a Phase III drug study in Peru, Genexion’s public registration matches.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Genexion, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the Peru regulatory path, see CRO in Peru: the First-in-Human CRO on the INS file. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the Genexion public pages linked above, Peru’s INS public registers and ClinicalTrials.gov, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • Impacta Peru vs a First-in-Human Device CRO (bioaccess®)

    If you typed Impacta into a search box, you are probably building a CRO or site shortlist for Peru. This article uses only what is public about Impacta (impactaperu.org) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What Impacta publishes

    Asociación Civil Impacta Salud y Educación is a Lima non-profit whose website centers on HIV research, education and community programs, and an institutional bioethics committee. It appears as ROIC-77 in the INS register of research organizations (OIC), and it is listed as a study site on ClinicalTrials.gov records for HIV prevention research with academic partners.

    Impacta vs bioaccess®

    Dimension Impacta bioaccess®
    Core focus Non-profit HIV prevention research site First-in-human and early feasibility studies for medical devices
    Geography Peru (Lima) Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need a Lima site with long experience in HIV prevention research, Impacta’s public record matches.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Impacta, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the Peru regulatory path, see CRO in Peru: the First-in-Human CRO on the INS file. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the Impacta public pages linked above, Peru’s INS public registers and ClinicalTrials.gov, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • Vía Libre Peru vs a First-in-Human Device CRO (bioaccess®)

    If you typed Vía Libre into a search box, you are probably building a CRO or site shortlist for Peru. This article uses only what is public about Vía Libre (vialibre.org.pe) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What Vía Libre publishes

    Asociación Vía Libre is a Lima non-profit focused on HIV. Its website describes a specialized health center, clinical laboratory, pharmacy, research activity and an institutional bioethics committee. It appears as ROIC-367 in the INS register of research organizations (OIC), and it is listed on ClinicalTrials.gov records for HIV research with academic partners.

    Vía Libre vs bioaccess®

    Dimension Vía Libre bioaccess®
    Core focus HIV NGO, research site and ethics committee First-in-human and early feasibility studies for medical devices
    Geography Peru (Lima) Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need a Lima research site or ethics review for HIV-related studies, Vía Libre’s public record matches.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Vía Libre, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the Peru regulatory path, see CRO in Peru: the First-in-Human CRO on the INS file. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the Vía Libre public pages linked above, Peru’s INS public registers and ClinicalTrials.gov, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.

  • Científica CRO Peru vs a First-in-Human Device CRO (bioaccess®)

    If you typed Científica CRO into a search box, you are probably building a CRO or site shortlist for Peru. This article uses only what is public about Científica CRO (cientificacro.com) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.

    What Científica CRO publishes

    Científica CRO SAC is a Lima-based (Pueblo Libre) CRO. Its website lists protocol and essential-document writing, feasibility and project management, clinical monitoring, regulatory affairs, active and passive pharmacovigilance, quality management, data management and statistics, systematic reviews, scientific writing, training and translations. It appears as ROIC-337 in the INS register of research organizations (OIC).

    Científica CRO vs bioaccess®

    Dimension Científica CRO bioaccess®
    Core focus Peru monitoring, regulatory, PV, medical writing First-in-human and early feasibility studies for medical devices
    Geography Peru (Lima) Latin America, since 2010
    Device FIH track record No named device first-in-human study found on the public pages reviewed Published case studies on bioaccessla.com
    After the trial See provider site Live multi-country sanitary registration and in-country holder service

    Where each one fits

    If you need Peru-based monitoring, regulatory, pharmacovigilance or writing support, Científica CRO’s published services match.

    If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including Científica CRO, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.

    For the Peru regulatory path, see CRO in Peru: the First-in-Human CRO on the INS file. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.

    Ready to compare a proposal? Request a first-in-human study proposal.

    Facts from the Científica CRO public pages linked above, Peru’s INS public registers and ClinicalTrials.gov, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.